Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385

The influence of drug-like concepts on decision-making in medicinal chemistry

Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Kwak, E. L., Sordella, R., Bell, D. W., Godin-Heymann, N., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Driscoll, D. R., Fidias, P., Lynch, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502860102 · Cited by 952

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892

Is There a Difference between Leads and Drugs? A Historical Perspective

Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769

The influence of lead discovery strategies on the properties of drug candidates

Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628

Chemistry and Structural Biology of Androgen Receptor

Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Burstein, H. J., Sun, Y., Dirix, L. Y., Jiang, Z., Paridaens, R., Tan, A. R., Awada, A., Ranade, A., Jiao, S., Schwartz, G., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8707 · Cited by 522

Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants

Das, K., Clark, Lewi, P. J., Heeres, J., de Jonge, M. R., Koymans, L. M. H., Vinkers, H. M., Daeyaert, F., Ludovici, D. W., Kukla, M. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030558s · Cited by 514

Combinatorial chemoprevention of intestinal neoplasia

Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., & Discafani, C. M. (2000) · Nature Medicine · doi:10.1038/79534 · Cited by 493

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Gauthier, J. Y., Chauret, N., Cromlish, W., Desmarais, S., Duong, L. T., Falgueyret, J.-P., Kimmel, D. B., Lamontagne, S., Léger, S., LeRiche, T., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.047 · Cited by 477

Isosterism and molecular modification in drug design

Thornber, C. W. (1979) · Chemical Society Reviews · doi:10.1039/cs9790800563 · Cited by 473

An Extremely Potent Inhibitor of Xanthine Oxidoreductase

Okamoto, K., Eger, B. T., Nishino, T., Kondo, S., Pai, E. F., & Nishino, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208307200 · Cited by 434

Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases

Card, G. L., England, B. P., Suzuki, Y., Fong, D., Powell, B., Lee, B., Luu, C., Tabrizizad, M., Gillette, S., Ibrahim, P. N., et al. (2004) · Structure · doi:10.1016/j.str.2004.10.004 · Cited by 432

Structural basis for antagonism and resistance of bicalutamide in prostate cancer

Bohl, C. E., Gao, W., Miller, D. D., Bell, C. E., & Dalton, J. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500381102 · Cited by 421

Discovery of Alogliptin: A Potent, Selective, Bioavailable, and Efficacious Inhibitor of Dipeptidyl Peptidase IV

Feng, J., Zhang, Z., Wallace, M. B., Stafford, J. A., Kaldor, S. W., Kassel, D. B., Navre, M., Shi, L., Skene, R. J., Asakawa, T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070104l · Cited by 405

Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?

Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368

The p KBHX Database: Toward a Better Understanding of Hydrogen-Bond Basicity for Medicinal Chemists

Laurence, C., Brameld, K. A., Graton, J., Le Questel, J.-Y., & Renault, E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801331y · Cited by 346

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

Tsou, H.-R., Overbeek-Klumpers, E. G., Hallett, W. A., Reich, M. F., Floyd, M. B., Johnson, B. D., Michalak, R. S., Nilakantan, R., Discafani, C., Golas, J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040159c · Cited by 301

Selectively Nonselective Kinase Inhibition: Striking the Right Balance

Morphy, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901132v · Cited by 292

The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition

Okamoto, K., Matsumoto, K., Hille, R., Eger, B. T., Pai, E. F., & Nishino, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400973101 · Cited by 286

Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects

Mizushige, K., Ueda, T., Yukiiri, K., & Suzuki, H. (2002) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2002.tb00085.x · Cited by 285

Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships

Singh, S., Gauthier, S., & Labrie, F. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375371 · Cited by 236

Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes

Bayram, M., De Luca, L., Massie, M. B., & Gheorghiade, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.021 · Cited by 234

The Small Molecule GMX1778 Is a Potent Inhibitor of NAD + Biosynthesis: Strategy for Enhanced Therapy in Nicotinic Acid Phosphoribosyltransferase 1-Deficient Tumors

Watson, M., Roulston, A., Bélec, L., Billot, X., Marcellus, R., Bédard, D., Bernier, C., Branchaud, S., Chan, H., Dairi, K., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00112-09 · Cited by 229

Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors

Das, K., Lewi, P. J., Hughes, S. H., & Arnold, E. (2005) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2004.07.001 · Cited by 225

The discovery and mechanism of action of letrozole

Bhatnagar, A. S. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9696-3 · Cited by 219

Pharmacokinetics of Citalopram in Relation to the Sparteine and the Mephenytoin Oxidation Polymorphisms

Sindrup, S. H., Brøsen, K., Hansen, M. G. J., Aaes-Jørgensen, T., Overø, K. F., & Gram, L. F. (1993) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199302000-00002 · Cited by 213

4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile Inhibitors of Epidermal Growth Factor Receptor Kinase and Their Bioisosteric Relationship to the 4-Anilino-6,7-dialkoxyquinazoline Inhibitors

Wissner, A., Berger, D. M., Boschelli, D. H., Floyd, M. B., Greenberger, L. M., Gruber, B. C., Johnson, B. D., Mamuya, N., Nilakantan, R., Reich, M. F., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000206a · Cited by 207

Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome

Lemoine, P., Kermadi, I., Garcia-Acosta, S., Garay, R. P., & Dib, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.08.015 · Cited by 180

Emerging anti-HIV drugs

De Clercq, E. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.241 · Cited by 163

A generally applicable method for assessing the electrophilicity and reactivity of diverse nitrile-containing compounds

Oballa, R. M., Truchon, J., Bayly, C. I., Chauret, N., Day, S., Crane, S. N., & Berthelette, C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.044 · Cited by 150

1,4-Cyclohexanecarboxylates: Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma

Christensen, S. B., Guider, A. M., Forster, C. J., Gleason, J. G., Bender, P. E., Karpinski, J. M., DeWolf, W. E., Barnette, M. S., Underwood, D. C., Griswold, D. E., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970090r · Cited by 150

Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors

Erlichman, C., Hidalgo, M. M., Boni, J. P., Martins, P., Quinn, S., Zacharchuk, C., Amorusi, P., Adjei, A. A., & Rowinsky, E. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.8960 · Cited by 149

Strontium ranelate improves implant osseointegration

Maı̈moun, L., Brennan‐Speranza, T. C., Badoud, I., Dubois-Ferrière, V., Rizzoli, R., & Ammann, P. (2010) · Bone · doi:10.1016/j.bone.2010.01.379 · Cited by 142

Hydrogen-bond acceptor properties of nitriles: a combined crystallographic andab initio theoretical investigation

Questel, J. L., Berthelot, M., & Laurence, C. (2000) · Journal of Physical Organic Chemistry · doi:10.1002/1099-1395(200006)13:6 · Cited by 142

Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

He, H., Tran, P., Yin, H., Smith, H. T., Batard, Y., Wang, L., Einolf, H. J., Gu, H., Mangold, J. B., Fischer, V., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023010 · Cited by 141

Discovery of (R)-7-Cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a Farnesyltransferase Inhibitor with Potent Preclinical Antitumor Activity

Hunt, J. T., Ding, C. Z., Batorsky, R. S., Bednarz, M. S., Bhide, R. S., Cho, Y. H., Chong, S., Chao, S. T., Gullo-Brown, J. L., Guo, P., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000248z · Cited by 135

Structure-Based Design of Potent Inhibitors of Scytalone Dehydratase: Displacement of a Water Molecule from the Active Site

Chen, J., Xu, S. L., Wawrzak, Z., Basarab, G. S., & Jordan, D. B. (1998) · Biochemistry · doi:10.1021/bi981848r · Cited by 134

In vitroantifungal activities of luliconazole, a new topical imidazole

Koga, H., Nanjoh, Y., Makimura, K., & Tsuboi, R. (2009) · Medical Mycology · doi:10.1080/13693780802541518 · Cited by 132

Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation

Metzler, W. J., Yanchunas, J., Weigelt, C. A., Kish, K., Klei, H. E., Xie, D., Zhang, Y., Corbett, M. J., Tamura, J. K., He, B., et al. (2008) · Protein Science · doi:10.1110/ps.073253208 · Cited by 132

NVP-DPP728 (1-[[[2-[(5-Cyanopyridin-2-yl)amino]ethyl]amino]acetyl]-2-cyano-(S)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase IV

Hughes, T. E., Mone, M. D., Russell, M. E., Weldon, S. C., & Villhauer, E. B. (1999) · Biochemistry · doi:10.1021/bi990852f · Cited by 129

A New Class of Nonsteroidal Aromatase Inhibitors: Design and Synthesis of Chromone and Xanthone Derivatives and Inhibition of the P450 Enzymes Aromatase and 17α-Hydroxylase/C17,20-Lyase

Recanatini, M., Bisi, A., Cavalli, A., Belluti, F., Gobbi, S., Rampa, A., Valenti, P., Palzer, M., Palusczak, A., & Hartmann, R. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000955s · Cited by 129

The Pharmacology of Citalopram Enantiomers: The Antagonism by R‐Citalopram on the Effect of S‐Citalopram*

Sánchez, C. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_295.x · Cited by 128

Recent advances in antifungal chemotherapy

Petrikkos, G. L., & Skiada, A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.03.009 · Cited by 128

Anticancer agent CHS-828 inhibits cellular synthesis of NAD

Olesen, U. H., Christensen, M. K., Björkling, F., Jäättelä, M., Jensen, P. B., Sehested, M., & Nielsen, S. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.019 · Cited by 126

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

Christopher, R. J., Covington, P. S., Davenport, M. P., Fleck, P. R., Mekki, Q. A., Wann, E. R., & Karim, A. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.03.005 · Cited by 125

Molecular Basis for the Aromatization Reaction and Exemestane-Mediated Irreversible Inhibition of Human Aromatase

Hong, Y., Yu, B., Sherman, M. A., Yuan, Y., Zhou, D., & Chen, S. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0281 · Cited by 123

Development of Nitrile-Based Peptidic Inhibitors of Cysteine Cathepsins

Frizler, M., Stirnberg, M., Sisay, M. T., et al. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790725452 · Cited by 120

Synthesis and Structure−Activity Relationship in a Class of Indolebutylpiperazines as Dual 5-HT1A Receptor Agonists and Serotonin Reuptake Inhibitors

Heinrich, T., Böttcher, H., Gericke, R., Bartoszyk, G. D., Anzali, S., Seyfried, C. A., Greiner, H. E., & van Amsterdam, C. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040793q · Cited by 119

Three-Dimensional Model of Lanosterol 14α-Demethylase from Cryptococcus neoformans : Active-Site Characterization and Insights into Azole Binding

Sheng, C., Miao, Z., Ji, H., Yao, J., Wang, W., Che, X., Dong, G., Lü, J., Guo, W. P., & Zhang, W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01630-08 · Cited by 118

Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem

Sanger, D. J., Morel, E., & Perrault, G. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00510-9 · Cited by 107

Pyrazole NNRTIs 4: Selection of UK-453,061 (lersivirine) as a Development Candidate

Mowbray, C. E., Burt, C., Corbau, R., Gayton, S., Hawes, M., Perros, M., Tran, I., Price, D. A., Quinton, F., Selby, M. D., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.080 · Cited by 104

The Efficacy and Safety of Cilomilast in COPD

Rennard, S. I., Knobil, K., Rabe, K. F., Morris, A. N., Schachter, N., Locantore, N., Canonica, G. W., Zhu, Y.-J., & Barnhart, F. (2008) · Drugs · doi:10.2165/0003495-200868002-00002 · Cited by 102

Interaction of Papain-like Cysteine Proteases with Dipeptide-Derived Nitriles

Löser, R., Schilling, K., Dimmig, E., & Gütschow, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050686b · Cited by 102

RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer

Lau, Y. S., Danks, L., Sun, S. G., Fox, S. B., Sabokbar, A., Harris, A. L., & Athanasou, N. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9438-y · Cited by 101

Farnesyl transferase inhibitors in clinical development

Caponigro, F., Casale, M., & Bryce, J. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.6.943 · Cited by 95

Characterization of cancer stem cells in chronic myeloid leukaemia

Jørgensen, H. G., & Holyoake, T. L. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351347 · Cited by 93

The Synthetic Compound CC-5079 Is a Potent Inhibitor of Tubulin Polymerization and Tumor Necrosis Factor-α Production with Antitumor Activity

Zhang, L., Wu, L., Raymon, H. K., Chen, R. S., Corral, L. G., Shirley, M. A., Narla, R. K., Gamez, J., Muller, G. W., Stirling, D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2083 · Cited by 93

Synthesis and Structure−Activity Relationship of Novel 6-Aryl-1,4- dihydrobenzo[d][1,3]oxazine-2-thiones as Progesterone Receptor Modulators Leading to the Potent and Selective Nonsteroidal Progesterone Receptor Agonist Tanaproget

Fensome, A., Bender, R. H. W., Chopra, R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050358b · Cited by 92

Bicalutamide (Casodex®) in the treatment of prostate cancer

Fradet, Y. (2004) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.4.1.37 · Cited by 92

Identification of Selective, Nonpeptidic Nitrile Inhibitors of Cathepsin S Using the Substrate Activity Screening Method

Patterson, A. W., Wood, W. J. L., Hornsby, M. J., Lesley, S. A., Spraggon, G., & Ellman, J. A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060701s · Cited by 92

Neratinib: an oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer

Bose, P., & Ozer, H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903305428 · Cited by 91

Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.

Pasqualotto, A. C., Thiele, K. O., & Goldani, L. Z. (2010) · PubMed · Cited by 90

Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.

Wikberg, T., Vuorela, A., Ottoila, P., et al. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07341-6 · Cited by 90

Carrageenan/MIV-150 (PC-815), a Combination Microbicide

Fernández-Romero, J. A., Thorn, M., Turville, S. G., Titchen, K., Sudol, K. M., Li, J., Miller, T., Robbiani, M., MAGUIRE, R. A., Buckheit, R. W., et al. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000223287.46097.4b · Cited by 90

Pharmacokinetic, pharmacodynamic, and efficacy profiles of alogliptin, a novel inhibitor of dipeptidyl peptidase-4, in rats, dogs, and monkeys

Lee, B., Shi, L., Kassel, D. B., Asakawa, T., Takeuchi, K., & Christopher, R. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.047 · Cited by 89

Urea−PETT Compounds as a New Class of HIV-1 Reverse Transcriptase Inhibitors. 3. Synthesis and Further Structure−Activity Relationship Studies of PETT Analogues

Högberg, M., Sahlberg, C., Engelhardt, P., Noréen, R., Kangasmetsä, J., Johansson, N. G., Öberg, B. F., Vrang, L., Zhang, H., Sahlberg, B.-L., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990095j · Cited by 89

Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application

Bonifácio, M. J., Archer, M., Rodrigues, M. L., Matias, P. M., Learmonth, D. A., Carrondo, M. A., & Soares-da-Silva, P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.795 · Cited by 88

Identification of a potent and selective non-basic cathepsin K inhibitor

Li, C. S., Deschênes, D., Desmarais, S., Falgueyret, J., Gauthier, J. Y., Kimmel, D. B., Léger, S., Massé, F., McGrath, M. E., McKay, D. J., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.12.071 · Cited by 88

Crystal Structures of the Anticancer Clinical Candidates R115777 (Tipifarnib) and BMS-214662 Complexed with Protein Farnesyltransferase Suggest a Mechanism of FTI Selectivity

Reid, T. S., & Beese, L. S. (2004) · Biochemistry · doi:10.1021/bi049723b · Cited by 86

New antiretroviral drugs: a review of the efficacy, safety, pharmacokinetics, and resistance profile of tipranavir, darunavir, etravirine, rilpivirine, maraviroc, and raltegravir

Hughes, C. A., Robinson, L. L., Tseng, A. L.-I., & MacArthur, R. D. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903176446 · Cited by 84

A Phase I Trial of the Dual Farnesyltransferase and Geranylgeranyltransferase Inhibitor L-778,123 and Radiotherapy for Locally Advanced Pancreatic Cancer

Martin, N. E., Brunner, T. B., Kiel, K. D., DeLaney, T. F., Regine, W. F., Mohiuddin, M., Rosato, E. F., Haller, D. G., Stevenson, J. P., Smith, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0248 · Cited by 83

The Two Enantiomers of Citalopram Bind to the Human Serotonin Transporter in Reversed Orientations

Koldsø, H., Severinsen, K., Tran, T. T. T., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja906923j · Cited by 83

Saxagliptin

Dhillon, S., & Weber, J. (2009) · Drugs · doi:10.2165/11201170-000000000-00000 · Cited by 82

Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Deacon, C. F., & Holst, J. J. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0030-9 · Cited by 81

A simple in vitro assay for assessing the reactivity of nitrile containing compounds

MacFaul, P. A., Morley, A., & Crawford, J. J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.105 · Cited by 77

Dual irreversible kinase inhibitors: Quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

Wissner, A., Fraser, H. L., Ingalls, C. L., Dushin, R. G., Floyd, M. B., Cheung, K., Nittoli, T., Ravi, M., Tan, X., & Loganzo, F. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.03.055 · Cited by 76

Nilvadipine antagonizes both Aβ vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice

Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 75

Aromatase inhibitors as potential cancer chemopreventives.

Kelloff, G. J., Lubet, R., Lieberman, R., Eisenhauer, K. M., Steele, V. E., Crowell, J. A., Hawk, E. T., Boone, C. W., & Sigman, C. C. (1998) · PubMed · Cited by 72

Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557

Schmitt‐Hoffmann, A. H., Roos, B., Spickermann, J., Heep, M., Péterfai, E., Edwards, D. J., & Stoeckel, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00319-09 · Cited by 72

11 Years of Cyanopyrrolidines as DPP-IV Inhibitors

Peters, J. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091000 · Cited by 71

In Vitro Activities of Ravuconazole (BMS-207147) against 541 Clinical Isolates of Cryptococcus neoformans

Yamazumi, T., Pfaller, M. A., Messer, S. A., Houston, A. K., Hollis, R. J., & Jones, R. N. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2883-2886.2000 · Cited by 71

Alogliptin: a new addition to the class of DPP-4 inhibitors

Rendell, M. (2009) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4312 · Cited by 66

Novel Multidrug Resistance Reversal Agents

Berger, D. M., Citarella, R., Dutia, M. D., Greenberger, L. M., Hallett, W., Paul, R., & Powell, D. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9804477 · Cited by 66

Vildagliptin: a new oral treatment for type 2 diabetes mellitus

Mathieu, C., & DEGRANDE, E. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3005 · Cited by 65

In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries

Verweij, P. E., González, G. M., Wiederhold, N. P., Lass‐Flörl, C., Warn, P. A., Heep, M., Ghannoum, M. A., & Guinea, J. (2009) · Journal of Chemotherapy · doi:10.1179/joc.2009.21.3.272 · Cited by 64

Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression

Khan, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903286396 · Cited by 64

Zidovudine/Lamivudine for HIV-1 Infection Contributes to Limb Fat Loss

van Vonderen, M. G. A., van Agtmael, M. A., Hassink, E. A. M., Milinkovic, A., Brinkman, K., Geerlings, S. E., Ristola, M. A., van Eeden, A., Danner, S. A., Reiss, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005647 · Cited by 63

Syntheses and EGFR and HER-2 kinase inhibitory activities of 4-anilinoquinoline-3-carbonitriles: analogues of three important 4-anilinoquinazolines currently undergoing clinical evaluation as therapeutic antitumor agents

Wissner, A., Floyd, M. B., Rabindran, S. K., Nilakantan, R., Greenberger, L. M., Shen, R., Wang, Y., & Tsou, H. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00598-x · Cited by 62

Dual aromatase–sulfatase inhibitors based on the anastrozole template: synthesis, in vitro SAR, molecular modelling and in vivo activity

Jackson, T., Woo, L. W. L., Trusselle, M. N., Chander, S. K., Purohit, A., Reed, M. J., & Potter, B. V. L. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b707768h · Cited by 60

The Two Enantiomers of Citalopram Bind to the Human Serotonin Transporter in Reversed Orientations

Koldsø, H., Severinsen, K., Tran, T. T. T., et al. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.2321 · Cited by 58

Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)

Lefranc, F., Yeaton, P., Brotchi, J., & Robert Kiss, A. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1021 · Cited by 57

Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

Pratley, R. E. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802694713 · Cited by 57

Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms

Renwick, A. B., Mistry, H., Ball, S. E., WALTERS, D. G., Kao, J., & Lake, B. G. (1998) · Xenobiotica · doi:10.1080/004982598239452 · Cited by 53

Structural Model for Phenylalkylamine Binding to L-type Calcium Channels

Cheng, R. C. K., Tikhonov, D. B., & Zhorov, B. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027326 · Cited by 53

Crystallographic Analysis Reveals that Anticancer Clinical Candidate L-778,123 Inhibits Protein Farnesyltransferase and Geranylgeranyltransferase-I by Different Binding Modes

Reid, T. S., Long, S. B., & Beese, L. S. (2004) · Biochemistry · doi:10.1021/bi049280b · Cited by 51

ROS-Independent Preconditioning in Neurons via Activation of mitoK ATP Channels by BMS-191095

Gáspár, T., Snipes, J. A., Busija, A. R., Kis, B., Domoki, F., Bari, F., & Busija, D. W. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600611 · Cited by 51

Levodopa/carbidopa/entacapone in Parkinson’s disease

Seeberger, L., & Hauser, R. A. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.64 · Cited by 51

Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia

Sato, T., Ashizawa, N., Matsumoto, K., Iwanaga, T., Nakamura, H., Inoue, T., & Nagata, O. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.091 · Cited by 48

INVEST revisited: review of findings from the International Verapamil SR–Trandolapril Study

Cooper‐DeHoff, R. M., Handberg, E. M., Mancia, G., Zhou, Q., Champion, A., Legler, U. F., & Pepine, C. J. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.102 · Cited by 47

Febuxostat

Pascual, E., Sivera, F., Yasothan, U., & Kirkpatrick, P. N. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2831 · Cited by 47

Pharmacodynamic profile of Zaleplon, a new non‐benzodiazepine hypnotic agent

Patat, A. A., Paty, I., & Hindmarch, I. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.310 · Cited by 45

Imaging Progesterone Receptor in Breast Tumors: Synthesis and Receptor Binding Affinity of Fluoroalkyl-Substituted Analogues of Tanaproget

Zhou, H., Lee, J., Mayne, C. G., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100052k · Cited by 45

Activity, pharmacokinetics and safety of lersivirine (UK-453,061), a next-generation nonnucleoside reverse transcriptase inhibitor, during 7-day monotherapy in HIV-1-infected patients

Fätkenheuer, G., Staszewski, S., Plettenburg, A., Hackman, F., Layton, G. R., McFadyen, L., Davis, J. D., & Jenkins, T. M. (2009) · AIDS · doi:10.1097/qad.0b013e32832fef5b · Cited by 43

Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women

Milani, M., Jha, G. G., & Potter, D. A. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s9 · Cited by 41

Structure/function of the inhibition of human 3β-hydroxysteroid dehydrogenase type 1 and type 2 by trilostane

Thomas, J. L., Mack, V. L., Glow, J. A., Moshkelani, D., Terrell, J. R., & Bucholtz, K. M. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.04.007 · Cited by 41

Synthesis, Biological Evaluation, and Molecular Modeling of 1-Benzyl-1H-imidazoles as Selective Inhibitors of Aldosterone Synthase (CYP11B2)

Roumen, L., Peeters, J. W., Emmen, J. M. A., Beugels, I. P. E., Custers, E. M. G., de Gooyer, M. E., Plate, R., Pieterse, K., Hilbers, P. A. J., Smits, J. F. M., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901356d · Cited by 41

Novel P2X7 receptor antagonists ease the pain

King, B. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707266 · Cited by 39

Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis?

Blake, G. M., Compston, J. E., & Fogelman, I. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090601 · Cited by 38

Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors

Qiao, L., Baumann, C. A., Crysler, C. S., Ninan, N. S., Abad, M. C., Spurlino, J. C., DesJarlais, R. L., Kervinen, J., Neeper, M. P., Bayoumy, S. S., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.09.037 · Cited by 38

Non‐competitive steroid inhibition of oestrogen receptor functions

Puddefoot, J. R., Barker, S., Glover, H. R., Malouitre, S. D. M., & Vinson, G. P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10547 · Cited by 37

Structural Insights into the ATP Binding Pocket of the Anaplastic Lymphoma Kinase by Site-Directed Mutagenesis, Inhibitor Binding Analysis, and Homology Modeling

Gunby, R. H., Ahmed, S., Sottocornola, R., Gasser, M., Redaelli, S., Mologni, L., Tartari, C. J., Belloni, V., Gambacorti-Passerini, C. B., & Scapozza, L. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060380k · Cited by 37

Structure-toxicity relationship of aliphatic nitriles

Tanii, H., & Hashimoto, K. (1984) · Toxicology Letters · doi:10.1016/0378-4274(84)90077-8 · Cited by 36

A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods

Tervo, A. J., Nyrönen, T., Ronkko, T. P., & Poso, A. (2003) · Journal of Computer-Aided Molecular Design · doi:10.1023/b:jcam.0000021831.47952.a7 · Cited by 33

Pyrazole NNRTIs 3: Optimisation of physicochemical properties

Mowbray, C. E., Corbau, R., Hawes, M., Jones, L. H., Mills, J. E. J., Perros, M., Selby, M. D., Stupple, P. A., Webster, R., & Wood, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.043 · Cited by 31

Ab Initio Study of Possible and Preferred Basic Site(s) in PolyfunctionalN,N1-Dimethyl-N-cyanoformamidine

Makowski, M., Raczyńska, E. D., & Chmurzyński, L. (2001) · The Journal of Physical Chemistry A · doi:10.1021/jp002458t · Cited by 29

Synthesis of 2-imidazolidinylidene propanedinitrile derivatives as stimulators of gastrointestinal motility. 1

Sasho, S., Obase, H., Ichikawa, S., Kitazawa, T., Nonaka, H., Yoshizaki, R., Ishii, A., & Shuto, K. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00057a007 · Cited by 29

Nilvadipine Prevents the Impairment of Spatial Memory Induced by Cerebral Ischemia Combined with .BETA.-Amyloid in Rats

Iwasaki, K., Egashira, N., Takagaki, Y., Yoshimitsu, Y., Hatip‐Al‐Khatib, I., Mishima, K., & Fujiwara, M. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.698 · Cited by 29

Lipoprotein Lipase Activator NO‐1886

Yin, W., & Tsutsumi, K. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00111.x · Cited by 28

6-Sulfonylchromenes as Highly Potent KATP-Channel Openers

Salamon, E., Mannhold, R., Weber, H., Lemoine, H., & Frank, W. C. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010999g · Cited by 28

Comparative investigations of genotoxic activity of five nitriles in the comet assay and the Ames test

Wu, J., Hseu, Y. C., Chen, C., Wang, S. H., & Chen, S. C. (2009) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2009.03.121 · Cited by 26

Phase I Trial of Weekly Paclitaxel and BMS-214662 in Patients with Advanced Solid Tumors

Bailey, H. H., Alberti, D. B., Thomas, J. P., Mulkerin, D. L., Binger, K., Gottardis, M. M., Martell, R. E., & Wilding, G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0158 · Cited by 25

Micellar electrokinetic chromatographic method for the determination of letrozole, citalopram and their metabolites in human urine

Rodrı́guez, J., Contento, A. M., Llerena, M. J. V., et al. (2008) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.01.067 · Cited by 24

Bosutinib

Keller, G., Schafhausen, P., & Brümmendorf, T. H. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-01222-8_9 · Cited by 24

Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complex.

Wojtczak, A., Luft, J. R., & Cody, V. (1993) · PubMed · doi:10.2210/pdb1tlm/pdb · Cited by 23

Antitumoural Effects of the Pyridyl Cyanoguanidine CHS 828 on Three Different Types of Neuroendocrine Tumours Xenografted to Nude Mice

Johanson, V., Arvidsson, Y., Kölby, L., Bernhardt, P., Swärd, C., Nilsson, O., & Ahlman, H. (2005) · Neuroendocrinology · doi:10.1159/000091754 · Cited by 21

Effect of calcium antagonist on cerebral blood flow and oxygen metabolism in patients with hypertension and chronic major cerebral artery occlusion: a positron emission tomography study

Ogasawara, K., NODA, A., YASUDA, S., Kobayashi, M., Yukawa, H., & OGAWA, A. (2003) · Nuclear Medicine Communications · doi:10.1097/00006231-200301000-00017 · Cited by 20

Double-blind study of cyamemazine and diazepam in the alcohol withdrawal syndrome

Favre, J. D., Allain, H., Aubin, H., Frija-Orvoën, E., Gillet, C., Lejoyeux, M., Payen, A., Weber, M., Garcia-Acosta, S., Kermadi, I., et al. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.718 · Cited by 19

2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2′,3′:4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists

Wang, Y., Duraiswami, C., Madauss, K. P., Tran, T. B., Williams, S. P., Deng, S.-J., Graybill, T. L., Hammond, M., Jones, D. G., Grygielko, E. T., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.100 · Cited by 18

Pharmacologic and Therapeutic Considerations in Hypertension Therapy With Calcium Channel Blockers: Focus on Verapamil

Sica, D. A., & Prisant, L. M. (2007) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2007.06504.x · Cited by 18

Pharmacokinetics and pharmacodynamics of terbogrel, a combined thromboxane A2 receptor and synthase inhibitor, in healthy subjects

Guth, B. D., Narjes, H., Schubert, H., Tanswell, P., Riedel, A., & Nehmiz, G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02083.x · Cited by 17

Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC

Rodrı́guez, J., Contento, A. M., & Fernández, L. M. (2009) · Electrophoresis · doi:10.1002/elps.200800495 · Cited by 17

Structural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complex.

Wojtczak, A., Luft, J. R., & Cody, V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53239-7 · Cited by 14

Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease

Gordin, A., & Brooks, D. J. (2007) · Journal of Neurology · doi:10.1007/s00415-007-4007-9 · Cited by 13

Spotlight on Bicalutamide 150mg in the Treatment of Locally Advanced Prostate Cancer1

Wellington, K., & Keam, S. J. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00008 · Cited by 13

Orally active PDE4 inhibitors with therapeutic potential

Ochiai, H., Ohtani, T., Ishida, A., Kishikawa, K., Obata, T., Nakai, H., & Toda, M. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.018 · Cited by 13

5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators

Kern, J. C., Terefenko, E. A., Trybulski, E. J., Berrodin, T. J., Cohen, J. D., Winneker, R. C., Yudt, M. R., Zhang, Z., Zhu, Y., & Zhang, P. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.008 · Cited by 11

Metabolite profiles of two [14C]-labelled catechol O-methyltransferase inhibitors, nitecapone and entacapone, in rat and mouse urine and rat bile

Wikberg, T., & Vuorela, A. (1994) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188833 · Cited by 11

Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women

Bertelli, G. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3856 · Cited by 9

Crystallization and preliminary crystallographic characterization of catechol-O-methyltransferase in complex with its cosubstrate and an inhibitor

Rodrigues, M. L., Archer, M., Bonifácio, M. J., Soares-da-Silva, P., & Carrondo, M. A. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901006539 · Cited by 9

Donitriptan Selectively Decreases Jugular Venous Oxygen Saturation in the Anesthetized Pig: Further Insights into Its Mechanism of Action Relevant to Headache Relief

Létienne, R., Verscheure, Y., Perez, M., Grand, B. L., Colpaert, F. C., & John, G. W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047225 · Cited by 8

An Update of Recent Trials with Vildagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes

Johnson, J. T., Golden, K. L., & Braceras, R. (2009) · Journal of Pharmacy Technology · doi:10.1177/875512250902500404 · Cited by 3

Enantioselective cyanation of benzylic C–H bonds via copper-catalyzed radical relay

Zhang, W., Wang, F., McCann, S. D., Wang, D., Chen, P., Stahl, S. S., & Liu, G. (2016) · Science · doi:10.1126/science.aaf7783 · Cited by 676

Photocatalytic Late-Stage C–H Functionalization

Bellotti, P., Huang, H.-M., Faber, T., & Glorius, F. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00478 · Cited by 623

Borrowing Hydrogen for Organic Synthesis

Reed-Berendt, B. G., Latham, D. E., Dambatta, M. B., & Morrill, L. C. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00125 · Cited by 485

Boosting Hydrogen Production by Anodic Oxidation of Primary Amines over a NiSe Nanorod Electrode

Huang, Y., Chong, X., Liu, C., Liang, Y., & Zhang, B. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201807717 · Cited by 458

The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time

Ertl, P., Altmann, E., & McKenna, J. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00754 · Cited by 429